AmacaThera announced today that it completed an oversubscribed $10.3 million Series A financing round.
Lumira Ventures led the Series A funding, with existing investors Viva BioInnovator and Sprout BioVentures contributing as well. New investors BDC Capital Women in Technology Venture Fund, Inveready, MBX Capital, CR Capital Management, StandUp Ventures and MaRS IAF participated, too, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.